2-(5-[1,3]Dithian-2-ylmethyl-3-methyl-2-oxo-2lambda*5*-[1,3,2]oxazaphospholidin-2-yloxyamino)-9-(2-hydroxy-ethoxymethyl)-1,2,3,9-tetrahydro-purin-6-one

ID: ALA80550

PubChem CID: 44316309

Max Phase: Preclinical

Molecular Formula: C16H27N6O6PS2

Molecular Weight: 494.54

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CC(CC2SCCCS2)OP1(=O)ONC1NC(=O)c2ncn(COCCO)c2N1

Standard InChI:  InChI=1S/C16H27N6O6PS2/c1-21-8-11(7-12-30-5-2-6-31-12)27-29(21,25)28-20-16-18-14-13(15(24)19-16)17-9-22(14)10-26-4-3-23/h9,11-12,16,18,20,23H,2-8,10H2,1H3,(H,19,24)

Standard InChI Key:  WUAZDAHYLNZCPU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -1.3708    1.2083    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.8917   -1.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2750   -2.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7292   -0.7667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6042   -2.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6042   -2.8917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5083   -1.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6750   -1.0625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7458    1.8583    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0583   -0.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7458    0.5583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4292   -2.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0000    0.5583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2208    0.3000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4958    0.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4958    1.8583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5000   -0.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0000    1.8583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2208   -0.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2208   -1.5000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9333   -0.2542    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1250   -2.4167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3625   -1.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7458    2.6083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0292   -2.1542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6583   -1.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9375   -1.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6458   -0.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2042   -1.9792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4500   -2.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7792   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  4  1  0
  3  7  1  0
  4 10  1  0
  5  2  1  0
  6  3  1  0
  7  8  1  0
  8 10  1  0
  9  1  1  0
 10 14  1  0
 11  1  1  0
 12  5  1  0
 13  1  1  0
 14 13  1  0
 15 11  1  0
 16  9  1  0
 17 15  1  0
 18  1  2  0
 19 17  1  0
 20 19  1  0
 21 19  1  0
 22  7  2  0
 23  5  1  0
 24  9  1  0
 25 23  1  0
 26 28  1  0
 27 20  1  0
 28 21  1  0
 29 30  1  0
 30 31  1  0
 31 25  1  0
 16 15  1  0
  3  2  2  0
 26 27  1  0
 12  6  2  0
M  END

Associated Targets(Human)

Raji (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4F (93 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

FM3A (1296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 494.54Molecular Weight (Monoisotopic): 494.1171AlogP: 0.83#Rotatable Bonds: 9
Polar Surface Area: 139.21Molecular Species: NEUTRALHBA: 12HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.55CX LogP: 0.48CX LogD: 0.48
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.22Np Likeness Score: -0.14

References

1. Kumar A, Coe PL, Jones AS, Walker RT, Balzarini J, De Clercq E..  (1990)  Synthesis and biological evaluation of some cyclic phosphoramidate nucleoside derivatives.,  33  (9): [PMID:2391680] [10.1021/jm00171a009]

Source